Apoptosis-reactivating agents for targeted anticancer therapy

   
Philchenkov A.A.1

1. R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, National Academy of Sciences of Ukraine
Section: Review
DOI: 10.18097/pbmc20135902119      PubMed Id: 23789342
Year: 2013  Volume: 59  Issue: 2  Pages: 119-143
The current knowledge on molecular mechanisms of apoptosis is presented focusing on the key elements of the extrinsic death receptor pathway as well as the intrinsic mitochondrial pathway. Disregulation of apoptotic pathways is considered as a key factor in the survival of cancer cells in response to conventional chemotherapeutic drugs or radiation therapy. Substances that selectively reactivate apoptosis in malignant cells are the promising candidate anticancer drugs, which have now entered various phases of clinical trials. The up-to-date techniques allowing for non-invasive in vivo visualization of apoptotic cells with special reference to therapy-induced cell death are briefly surveyed.
Download PDF:
Keywords: apoptosis, targeted therapy, cancer patients, clinical trials, single photon emission computed tomography, positron emission tomography, extracellular markers of apoptosis
Citation:

Philchenkov, A. A. (2013). Apoptosis-reactivating agents for targeted anticancer therapy. Biomeditsinskaya khimiya, 59(2), 119-143.
This paper is also available as the English translation: 10.1134/S1990750812030043
References  
 2022 (vol 68)
 2021 (vol 67)
 2020 (vol 66)
 2019 (vol 65)
 2018 (vol 64)
 2017 (vol 63)
 2016 (vol 62)
 2015 (vol 61)
 2014 (vol 60)
 2013 (vol 59)
 2012 (vol 58)
 2011 (vol 57)
 2010 (vol 56)
 2009 (vol 55)
 2008 (vol 54)
 2007 (vol 53)
 2006 (vol 52)
 2005 (vol 51)
 2004 (vol 50)
 2003 (vol 49)